- All Drug Categories
- Home
- Anti-cancer Drugs
- Healthcare Products
- Medical Information
- Statement
Osimertinib can be taken for a long time under specific circumstances, but strict adherence to indications and tolerability assessments is requ...
Osimertinib, as a targeted drug for EGFR mutant non-small cell lung cancer, has clear contraindication requirements, including specific disease...
Pralsetinib is a targeted therapy drug primarily used for cancer patients with specific gene mutations. Its common side effects include interst...
Pralsetinib is a targeted drug used to treat specific RET fusion positive tumors. When using it, attention should be paid to multiple risks suc...
Cabozantinib is a multi-target tyrosine kinase inhibitor that requires strict monitoring of risks such as bleeding, thrombosis, and wound heali...
Cabozantinib is a multi-target tyrosine kinase inhibitor with broad-spectrum anti-cancer effects, known as the "panacea" of targeted drugs. Thi...
Cabozantinib is a multi-target tyrosine kinase inhibitor, and its side effects can be classified into severe reactions that require immediate m...
The side effects of Sotorasib can be divided into common reactions that can be self relieved and serious adverse reactions that require urgent ...
Sotorasib is a targeted therapy drug, and special attention should be paid to adverse reactions such as liver toxicity and interstitial lung di...
The standard dose of Sotorasib is 960mg orally per day, which needs to be adjusted in a stepwise manner according to adverse reactions. Specifi...
